Inglês

Eligibility Criteria

9 Formulários  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, affection status, consent group, subject source, and source subject ID of participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    3. Subject ID, sample ID, sample source, source sample ID, study accession ID, and sample use variable obtained from participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    4. Subject ID, age, gender of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    5. Sample ID, analyte type, body site, and histological type of tumors of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    6. Subject ID, age, gender, and race of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    7. Sample ID, analyte type, body site where sample was obtained, sequencing center, tumor specimen, and tumor status of sample of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    8. Subject ID, gender, diagnosis age, race, and study stage of participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
    9. Sample ID, analyte type, body site where sample was obtained, sequences center, and tumor status of sample obtained from participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
Inclusion and exclusion criteria
Descrição

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Patient Inclusion Criteria: with informative pathological diagnosis, good DNA quality and quantity.
Descrição

Elig.phs000725.v2.p1.1

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0205469
UMLS CUI [1,3]
C0011900
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C0205170
UMLS CUI [2,3]
C0012854
UMLS CUI [2,4]
C0332306
UMLS CUI [2,5]
C1265611
Voltar ao início da página

Similar models

Eligibility Criteria

9 Formulários
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID, affection status, consent group, subject source, and source subject ID of participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    3. Subject ID, sample ID, sample source, source sample ID, study accession ID, and sample use variable obtained from participants with or without rare cancer tumors and involved in the "Rare Cancer Tumors Project" project.
    4. Subject ID, age, gender of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    5. Sample ID, analyte type, body site, and histological type of tumors of participants with or without intracranial germ cell tumors and involve in the "Whole-exome Sequencing of Intracranial Germ Cell Tumors performed at Human Genome Sequencing Center, Baylor College of Medicine" project.
    6. Subject ID, age, gender, and race of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    7. Sample ID, analyte type, body site where sample was obtained, sequencing center, tumor specimen, and tumor status of sample of participants with or without craniopharyngioma tumors and involved in the "Whole Exome Sequencing of Craniopharyngioma Tumors at Human Genome Sequencing Center, Baylor College of Medicine" project.
    8. Subject ID, gender, diagnosis age, race, and study stage of participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
    9. Sample ID, analyte type, body site where sample was obtained, sequences center, and tumor status of sample obtained from participants with or without Sezary Syndrome and involved in the "Integrated Genomic Analysis of Sezary Syndrome at the Human Genome Sequencing Center, Baylor College of Medicine" project.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000725.v2.p1.1
Item
Patient Inclusion Criteria: with informative pathological diagnosis, good DNA quality and quantity.
boolean
C1512693 (UMLS CUI [1,1])
C0205469 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C1512693 (UMLS CUI [2,1])
C0205170 (UMLS CUI [2,2])
C0012854 (UMLS CUI [2,3])
C0332306 (UMLS CUI [2,4])
C1265611 (UMLS CUI [2,5])
Voltar ao início da página